Core Viewpoint - 正品控股有限公司 has submitted a listing application to the Hong Kong Stock Exchange, with Hongbo Capital Limited as its sole sponsor. The company primarily engages in the development, sales, marketing, and distribution of health and beauty supplements and products in Hong Kong [1]. Group 1: Company Overview - 正品控股 is ranked seventh among local suppliers of health and beauty supplements in Hong Kong, with a market share of approximately 1.6% based on retail value in 2024 [1]. - The company offers a diverse product portfolio catering to various age groups, focusing on niche markets such as deer-related health supplements, joint and pain relief products, and topical analgesics [1][2]. Group 2: Product and Market Position - In the deer-related health supplement market, 正品控股 holds the top position with a market share of about 29.4% in 2024. Its proprietary brand "炎痛消" includes some of the best-selling joint and pain relief products at Mannings retail stores [2]. - The company's products are categorized into two main types: health supplements and beauty supplements, with sales from these categories accounting for approximately 98.8%, 98.8%, and 98.2% of total revenue during the reporting periods [2]. Group 3: Financial Performance - For the fiscal years 2023, 2024, and 2025, the company reported revenues of approximately HKD 43 million, HKD 110 million, and HKD 130 million, respectively. The net profit and total comprehensive income for the same periods were approximately HKD 11.31 million, HKD 35.48 million, and HKD 36.26 million [3].
新股消息 正品控股递表港交所 于2024年在香港鹿相关保健补充品及产品的零售值排名第一
Jin Rong Jie·2025-07-30 00:10